TagCD4+ count

Case report: HIV-associated neurocognitive disorder & myelopathy in patient with preserved CD4, but high viral load

C

HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.  Ayele, B.A., Amogne, W. & Gemechu, L. BMC Infect Dis 20, 574 (2020). This case supports the current understanding regarding the persistent occurrence of HIV-associated neurocognitive disorder and HIV...

Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know

C

CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...

HIV diagnoses hit seven year low: Australia’s annual HIV figures released

H

Kirby Institute, UNSW, Monday, 24 September 2018 Australia has recorded its lowest level of HIV diagnoses in seven years, according to a new report from the Kirby Institute at UNSW Sydney. The report, released at the Australasian HIV&AIDS Conference in Sydney, found that there were 963 new HIV diagnoses in 2017, the lowest number since 2010. Researchers are attributing the promising results...

Stillbirth more frequent in women with HIV in UK than in general population

S

nam/aidsmap, 01 August 2017 The stillbirth rate among women living with HIV in the UK and Ireland from 2007 to 2015 was more than twice that of the general population, Graziella Favarato, presenting on behalf of the National Study of HIV in Pregnancy and Childhood (NSHPC), told participants at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris last week. Most women...

HIV life expectancy ‘near normal’ thanks to new drugs

H

BBC news, 11 May 2017 Young people on the latest HIV drugs now have near-normal life expectancy because of improvements in treatments, a new study in The Lancet suggests. Twenty-year-olds who started antiretroviral therapy in 2010 are projected to live 10 years longer than those first using it in 1996, it found. Doctors say that starting treatment early is crucial to achieve a long and healthy...

Studies look at brain and cognitive changes in people with HIV as they age

S

  nam/aidsmap, published: 14 March 2017 People with HIV often show persistent signs of cognitive impairment and abnormalities in brain structure despite suppressive antiretroviral therapy (ART), but they do not appear to experience accelerated decline compared to HIV-negative people as they age, according to research presented at the 2017 Conference on Retroviruses and Opportunistic...

Your sidebar area is currently empty. Hurry up and add some widgets.